Star Biologics, Inc.
Records under this name other than patents Star Biologics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 4 of 4 · Back to Star Biologics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,889,397 | Nucleotides for prevention and treatment of bacterial and fungal pathologies Formerly held Lapsed on the fee record Ended Nov 18, 2018 · USPTO record | Lapsed on the fee record | Ended Nov 18, 2018 | USPTO record |
| US 8,828,958 | Single-stranded antimicrobial oligonucleotides and uses thereof Formerly held Lapsed on the fee record Ended Sep 9, 2018 · USPTO record | Lapsed on the fee record | Ended Sep 9, 2018 | USPTO record |
| US 6,054,299 | Stem-loop cloning vector and method Formerly held Term ended Term ended Jun 17, 2017 · USPTO record | Term ended | Term ended Jun 17, 2017 | USPTO record |
| US 7,419,964 | Treatment of HSV-related pathologies using ssDNA Formerly held Lapsed on the fee record Ended Sep 2, 2016 · USPTO record | Lapsed on the fee record | Ended Sep 2, 2016 | USPTO record |